Frazier Life Sciences Management, L.P. Q2 2024 Filing
Filed August 15, 2024
Portfolio Value
$2.1T
Holdings
49
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 12,226,943 | $234.9B | 10.99% | |
| 2 | MIRMMIRUM PHARMACEUTICALS INC | 6,495,392 | $222.1B | 10.39% | |
| 3 | KRYSKRYSTAL BIOTECH INC | 988,460 | $181.5B | 8.49% | |
| 4 | HLVXHILLEVAX INC | 10,617,062 | $153.5B | 7.18% | |
| 5 | PHATPHATHOM PHARMACEUTICALS INC | 10,109,279 | $104.1B | 4.87% | |
| 6 | RYTMRHYTHM PHARMACEUTICALS INC | 2,371,304 | $97.4B | 4.55% | |
| 7 | BBIOBRIDGEBIO PHARMA INC | 3,632,604 | $92.0B | 4.30% | |
| 8 | ARQTARCUTIS BIOTHERAPEUTICS INC | 8,785,284 | $81.7B | 3.82% | |
| 9 | IRONDISC MEDICINE INC | 1,754,834 | $79.1B | 3.70% | |
| 10 | PCVXVAXCYTE INC | 1,039,405 | $78.5B | 3.67% | |
| 11 | EWTXEDGEWISE THERAPEUTICS INC | 3,731,067 | $67.2B | 3.14% | |
| 12 | ANABANAPTYSBIO INC | 2,165,591 | $54.3B | 2.54% | |
| 13 | VRNAVERONA PHARMA PLC | 3,314,349 | $47.9B | 2.24% | |
| 14 | KALVKALVISTA PHARMACEUTICALS INC | 3,687,867 | $43.4B | 2.03% | |
| 15 | TARSTARSUS PHARMACEUTICALS INC | 1,587,527 | $43.1B | 2.02% | |
| 16 | RVMDREVOLUTION MEDICINES INC | 997,455 | $38.7B | 1.81% | |
| 17 | ERASERASCA INC | 16,216,216 | $38.3B | 1.79% | |
| 18 | AGIOAGIOS PHARMACEUTICALS INC | 871,974 | $37.6B | 1.76% | |
| 19 | SLNOSOLENO THERAPEUTICS INC | 875,667 | $35.7B | 1.67% | |
| 20 | RCKTROCKET PHARMACEUTICALS INC | 1,561,230 | $33.6B | 1.57% | |
| 21 | YB4PSAVARA INC | 8,157,385 | $32.9B | 1.54% | |
| 22 | ORICORIC PHARMACEUTICALS INC | 4,142,855 | $29.3B | 1.37% | |
| 23 | CGONCG ONCOLOGY INC | 770,000 | $24.3B | 1.14% | |
| 24 | PEPGPEPGEN INC | 1,502,788 | $24.0B | 1.12% | |
| 25 | MRUSMERUS N V | 373,100 | $22.1B | 1.03% | |
| 26 | TRVITREVI THERAPEUTICS INC | 7,381,090 | $22.0B | 1.03% | |
| 27 | SLNSILENCE THERAPEUTICS PLC | 1,148,591 | $21.8B | 1.02% | |
| 28 | RAREULTRAGENYX PHARMACEUTICAL IN | 425,000 | $17.5B | 0.82% | |
| 29 | AUTLAUTOLUS THERAPEUTICS PLC | 4,623,324 | $16.1B | 0.75% | |
| 30 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 393,000 | $16.1B | 0.75% | |
| 31 | MREOMEREO BIOPHARMA GROUP PLC | 4,401,371 | $15.8B | 0.74% | |
| 32 | IMTXIMMATICS N.V | 1,152,456 | $13.4B | 0.63% | |
| 33 | TYRATYRA BIOSCIENCES INC | 832,220 | $13.3B | 0.62% | |
| 34 | MGNXMACROGENICS INC | 3,010,727 | $12.8B | 0.60% | |
| 35 | APLTAPPLIED THERAPEUTICS INC | 2,286,135 | $10.7B | 0.50% | |
| 36 | PBYIPUMA BIOTECHNOLOGY INC | 3,062,558 | $10.0B | 0.47% | |
| 37 | ETNBGBP89BIO INC | 1,000,000 | $8.0B | 0.37% | |
| 38 | —ELEVATION ONCOLOGY INC | 2,958,579 | $8.0B | 0.37% | |
| 39 | COGTCOGENT BIOSCIENCES INC | 936,576 | $7.9B | 0.37% | |
| 40 | ACADACADIA PHARMACEUTICALS INC | 470,338 | $7.6B | 0.36% | |
| 41 | ARVNARVINAS INC | 285,331 | $7.6B | 0.36% | |
| 42 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,069,244 | $7.3B | 0.34% | |
| 43 | ALLOALLOGENE THERAPEUTICS INC | 2,867,750 | $6.7B | 0.31% | |
| 44 | ANTXAN2 THERAPEUTICS INC | 2,088,889 | $4.5B | 0.21% | |
| 45 | NAMSNEWAMSTERDAM PHARMA COMPANY | 500,333 | $4.4B | 0.20% | |
| 46 | DSGNDESIGN THERAPEUTICS INC | 1,195,179 | $4.0B | 0.19% | |
| 47 | IMCRIMMUNOCORE HLDGS PLC | 108,762 | $3.7B | 0.17% | |
| 48 | MGXMETAGENOMI INC | 245,692 | $1.0B | 0.05% | |
| 49 | ACRSACLARIS THERAPEUTICS INC | 264,377 | $290.8M | 0.01% |